Jubilant Ingrevia Limited
Jubilant Ingrevia Limited (JUBLINGREA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
jubilantingrevia.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,020 Cr | 966 Cr | 1,074 Cr | 1,024 Cr | 1,045 Cr | 1,057 Cr | 1,051 Cr | 1,038 Cr | 1,121 Cr | 1,051 Cr | 1,179 Cr | 1,300 Cr |
| Operating expenses (approx.) | 902 Cr | 871 Cr | 983 Cr | 915 Cr | 921 Cr | 918 Cr | 905 Cr | 896 Cr | 985 Cr | 924 Cr | 1,016 Cr | 1,101 Cr |
| EBITDA | 118 Cr | 96 Cr | 91 Cr | 110 Cr | 125 Cr | 138 Cr | 147 Cr | 142 Cr | 136 Cr | 127 Cr | 163 Cr | 199 Cr |
| OPM % | 11.5% | 9.9% | 8.5% | 10.7% | 11.9% | 13.1% | 14.0% | 13.7% | 12.1% | 12.0% | 13.8% | 15.3% |
| Other income | 9 Cr | 9 Cr | 10 Cr | 10 Cr | 10 Cr | 9 Cr | 8 Cr | 11 Cr | 11 Cr | 9 Cr | 9 Cr | 10 Cr |
| Interest | 13 Cr | 15 Cr | 14 Cr | 14 Cr | 15 Cr | 12 Cr | 14 Cr | 13 Cr | 12 Cr | 12 Cr | 12 Cr | 17 Cr |
| Depreciation | 34 Cr | 34 Cr | 36 Cr | 39 Cr | 40 Cr | 40 Cr | 39 Cr | 41 Cr | 41 Cr | 45 Cr | 48 Cr | 51 Cr |
| Profit before tax | 80 Cr | 55 Cr | 51 Cr | 66 Cr | 80 Cr | 96 Cr | 102 Cr | 100 Cr | 93 Cr | 65 Cr | 112 Cr | 141 Cr |
| Tax % | 28.0% | 30.0% | 43.0% | 26.2% | 26.5% | 27.4% | 27.2% | 24.7% | 25.2% | 28.3% | 22.6% | 24.9% |
| Net profit | 57 Cr | 39 Cr | 29 Cr | 49 Cr | 59 Cr | 69 Cr | 74 Cr | 75 Cr | 69 Cr | 47 Cr | 86 Cr | 106 Cr |
| EPS (₹) | ₹3.64 | ₹2.44 | ₹1.85 | ₹3.08 | ₹3.73 | ₹4.39 | ₹4.69 | ₹4.75 | ₹4.40 | ₹2.97 | ₹5.47 | ₹6.70 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 684 Cr | 4,949 Cr | 4,773 Cr | 4,136 Cr | 4,178 Cr | 4,388 Cr | Sign in for TTM |
| Operating expenses (approx.) | 567 Cr | 4,118 Cr | 4,226 Cr | 3,715 Cr | 3,659 Cr | 3,821 Cr | Sign in for TTM |
| EBITDA | 117 Cr | 832 Cr | 547 Cr | 421 Cr | 519 Cr | 567 Cr | Sign in for TTM |
| OPM % | 17.1% | 16.8% | 11.5% | 10.2% | 12.4% | 12.9% | Sign in for TTM |
| Other income | 3 Cr | 31 Cr | 33 Cr | 35 Cr | 38 Cr | 41 Cr | Sign in for TTM |
| Interest | 7 Cr | 31 Cr | 22 Cr | 53 Cr | 56 Cr | 49 Cr | Sign in for TTM |
| Depreciation | 22 Cr | 123 Cr | 122 Cr | 136 Cr | 158 Cr | 175 Cr | Sign in for TTM |
| Profit before tax | 77 Cr | 709 Cr | 437 Cr | 268 Cr | 344 Cr | 370 Cr | Sign in for TTM |
| Tax % | 29.8% | 32.8% | 29.6% | 31.7% | 26.9% | 24.8% | Sign in for TTM |
| Net profit | 54 Cr | 477 Cr | 308 Cr | 183 Cr | 251 Cr | 278 Cr | Sign in for TTM |
| EPS (₹) | ₹20.78 | ₹29.98 | ₹19.34 | ₹11.56 | ₹15.89 | ₹17.59 | Sign in for TTM |
| Dividend payout % | — | 9.5% | 25.8% | 43.0% | 31.8% | 28.5% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 16 Cr | 16 Cr | 16 Cr | 16 Cr | 16 Cr | 16 Cr |
| Reserves | 1,907 Cr | 2,417 Cr | 2,650 Cr | 2,722 Cr | 2,911 Cr | 3,110 Cr |
| Borrowings | — | — | 397 Cr | 733 Cr | 764 Cr | 792 Cr |
| Other liabilities | 1,456 Cr | 1,364 Cr | 1,196 Cr | 1,261 Cr | 1,341 Cr | 1,566 Cr |
| Total liabilities | 3,379 Cr | 3,797 Cr | 4,259 Cr | 4,732 Cr | 5,032 Cr | 5,484 Cr |
| Fixed assets (net) | — | — | 1,788 Cr | 2,478 Cr | 2,558 Cr | 3,148 Cr |
| CWIP | — | — | 525 Cr | 331 Cr | 525 Cr | 154 Cr |
| Investments | — | — | 8 Cr | 16 Cr | 37 Cr | 33 Cr |
| Loans & advances | — | — | 0.53 Cr | 0.43 Cr | 0.32 Cr | 0.43 Cr |
| Inventories | — | — | 1,035 Cr | 941 Cr | 943 Cr | 880 Cr |
| Trade receivables | — | — | 511 Cr | 572 Cr | 607 Cr | 783 Cr |
| Cash & bank | — | — | 73 Cr | 79 Cr | 69 Cr | 188 Cr |
| Other assets | 3,379 Cr | 3,797 Cr | 319 Cr | 316 Cr | 292 Cr | 297 Cr |
| Total assets | 3,379 Cr | 3,797 Cr | 4,259 Cr | 4,732 Cr | 5,032 Cr | 5,484 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | — | 453 Cr | 462 Cr | 430 Cr | 508 Cr | 524 Cr |
| Cash from investing | — | -72 Cr | -472 Cr | -569 Cr | -393 Cr | -276 Cr |
| Cash from financing | — | -418 Cr | 42 Cr | 144 Cr | -129 Cr | -155 Cr |
| Net cash flow | — | -36 Cr | 35 Cr | 6 Cr | -9 Cr | 119 Cr |
| Free cash flow (OCF − Capex) | — | 223 Cr | -19 Cr | -138 Cr | 142 Cr | 225 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 4.4% | 30.4% | 15.0% | 9.2% | 10.8% | 10.7% |
| ROE % | 2.8% | 19.6% | 11.5% | 6.7% | 8.6% | 8.9% |
| Debtor days | — | — | 39 | 50 | 53 | 65 |
| Inventory days | — | — | 148 | 168 | 167 | 152 |
| Days payable | — | — | 114 | 137 | 145 | 163 |
| Cash conversion cycle | — | — | 72 | 82 | 76 | 54 |
| Debt / equity | 0.00 | 0.00 | 0.15 | 0.27 | 0.26 | 0.25 |
| Current ratio | — | — | 1.54 | 1.38 | 1.32 | 1.29 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.59 | 1.55 | 1.34 | 1.06 |
Compare with peers
Loading peers…